WHO praises AstraZeneca COVID-19 vaccine trial pause

Deutschland Nachrichten Nachrichten

WHO praises AstraZeneca COVID-19 vaccine trial pause
Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen
  • 📰 Reuters
  • ⏱ Reading Time:
  • 12 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 97%

A World Health Organization official on Tuesday said that the decision by AstraZeneca to pause global trials of its experimental coronavirus vaccine after an unexplained illness showed the firm was prioritising safety.

“This is what we want to see with trials, it is a well-run trial. Safety is always critical, it is crucial and they have looked at that in an appropriate manner,” Margaret Harris told journalists in Geneva.

Asked to react to experimental COVID-19 vaccine use in China and Russia, she said: “The WHO would like to see vaccines go head to head so we can have clear information and to see these results against each other.”

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

Reuters /  🏆 2. in US

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

AstraZeneca's COVID-19 vaccine trial in the U.S. remains halted: reportAstraZeneca's COVID-19 vaccine trial in the U.S. remains halted: reportU.S. trials of AstraZeneca Plc.'s undefined and Oxford University COVID-19 vaccine candidate will be on hold until at least midweek, pending a Federal Drug...
Weiterlesen »

AstraZeneca COVID-19 vaccine trials resume in BrazilAstraZeneca COVID-19 vaccine trials resume in BrazilClinical trials for the coronavirus vaccine being developed by AstraZeneca PLC and Oxford University resumed in Brazil on Monday after the country's health regulator got confirmation over the weekend that its British equivalent MHRA had approved the restart, a company representative...
Weiterlesen »

Vaccine maker got $1 billion from taxpayers. Now it's boosting drug pricesVaccine maker got $1 billion from taxpayers. Now it's boosting drug pricesOne of the world’s largest drug companies has been aggressively raising prices even as it received hundreds of millions of dollars of U.S. government aid to develop a COVID-19 vaccine.
Weiterlesen »

Exclusive: AstraZeneca COVID-19 vaccine trial in U.S. on hold until at least midweek - sourcesAstraZeneca's COVID-19 vaccine trial remains on hold in the United States pending a U.S. investigation into a serious side effect in Britain even as other trials of the vaccine resume, sources familiar with the details told Reuters.
Weiterlesen »

When will there be a COVID-19 vaccine and should you trust that it's safe?When will there be a COVID-19 vaccine and should you trust that it's safe?Americans want a COVID-19 vaccine—but worry that it could be rushed out before the election. Here's what the science says.
Weiterlesen »

Stocks jump at the open on vaccine, merger newsStocks jump at the open on vaccine, merger newsU.S. stocks opened higher Monday, buoyed by deal-making and prospects for a COVID-19 vaccine. The Dow Jones Industrial Average undefined rose 192 points,...
Weiterlesen »



Render Time: 2025-03-12 21:03:26